Former Medtronic CEO Bill Hawkins Joins Ketryx Board to Tackle AI Compliance

Ketryx, the agentic continuous compliance platform for safety-critical product development, has announced that William A. Hawkins, former Chairman and CEO of Medtronic, has joined its Board of Directors. Hawkins, a highly respected leader in the medical technology industry, brings decades of experience in navigating regulatory landscapes and driving innovation. His appointment signals Ketryx's commitment to solving the AI bottleneck in life sciences, as highlighted in the full announcement click here. Hawkins also participated in the company's Series B financing, underscoring his confidence in Ketryx's mission.

Ketryx helps companies in safety-critical industries—including medical devices, pharmaceuticals, and robotics—accelerate product development by automatically generating compliant documentation, maintaining continuous traceability, and enabling safe and verifiable AI at scale in the tools teams already use. Trusted by four of the world's top five medical device manufacturers, its platform overlays existing tools to automate documentation, create traceability, and accelerate release cycles without disrupting workflows. Ketryx AI Agents reduce manual work by up to 90 percent and help teams identify and close compliance gaps, improving both speed and quality across the product lifecycle.

This news matters because the integration of AI in life sciences has been hampered by stringent regulatory requirements. By automating compliance, Ketryx allows innovators to focus on developing life-saving products without getting bogged down by paperwork. Hawkins' involvement brings credibility and strategic insight as the company scales. For more information, visit www.ketryx.com.